Suchergebnisse - "Arthritis"

PubPharm (1.293)

1

Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients

enthalten in: Clinical rheumatology | 2023

von Sobue, Y. | Suzuki, M. | Ohashi, Y. | +12

2

Diosgenin, a steroidal sapogenin, arrests arthritis through modulation of inflammatory cytokines and oxidative stress biomarkers in Wistar rats

enthalten in: Inflammopharmacology | 2023

von Javed, M. | Saleem, A. | Akhtar, M.

3

Methotrexate plus electroacupuncture reduces autophagy in ankle synovial tissue in rats with rheumatoid arthritis

enthalten in: American journal of translational research | 2023

von Sun, J. | Zhai, W. | Wang, Z. | +1

4

Effects of methotrexate combined with tocilizumab on growth and bone metabolism in children with juvenile idiopathic arthritis

enthalten in: American journal of translational research | 2023

von Yang, H. | Lan, C. | Xie, J. | +4

5

Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study

enthalten in: Egyptian rheumatology & rehabilitation | 2022

von Nagafuchi, H. | Goto, Y. | Kiyokawa, T. | +1

6

Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials

enthalten in: Rheumatology and therapy | 2022

von Tanaka, Y. | Atsumi, T. | Aletaha, D. | +7

7

Frequency and Pattern of Rheumatoid Arthritis in a Tertiary Hospital in Maiduguri, North-Eastern Nigeria

enthalten in: West African journal of medicine | 2022

von Yerima, A. | Hassan, U. | Faruk, H. | +1

8

Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2022

von Schäfer, A. | Kovacs, M. | Eder, A. | +2

9

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results

enthalten in: Clinical rheumatology | 2022

von Coates, L. | Mease, P. | Kronbergs, A. | +6

10

Oral methotrexate at doses 15–25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

enthalten in: Clinical rheumatology | 2022

von Wang, F. | Tang, J. | Li, Z. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[130]